CompletedPhase 4ACTRN12611000639921

Comparison between two clomiphene citrate protocols for induction of ovulation in clomiphene resistant Polycystic ovarian disease.

Sponsor

Mervat Sheikh Elarab Elsedeek Omran

Enrollment

200 participants

Start Date

Jan 1, 2009

Study Type

Interventional

Conditions

Resistant Anovulation Polycystic ovarian disease.

Summary

The primary purpose of the study is to test if either doubling the dose of clomiphene citrate or doubling the duration would make previously unresponsive patients respond and ovulate, and to compare the efficacy of either approach.

Eligibility

Sex: FemalesMin Age: 20 YearssMax Age: 35 Yearss

Plain Language Summary

Simplified for easier understanding

This trial compares two different dosing approaches of clomiphene citrate for women aged 20-35 with polycystic ovarian disease who have not responded to the drug in previous cycles. The goal is to find a more effective protocol to stimulate ovulation in treatment-resistant cases.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

clomiphene citrate oral tablets 100 mg daily for 10 days, starting within 5 days of induced menses.

Locations(1)

Egypt

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12611000639921